NOR-90systemic sclerosiscancerSScinterstitial lung diseaseSSc-autoantibodiesEuroimmuncalcinosisarthritispulmonary hypertension
…Introduction Autoantibodies against NOR-90 are rare and have been associated with systemic sclerosis (SSc)…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
N-Acetyl Cysteine7PPIs7Streptozotocin7fondaparinux7high-dose corticosteroids7hydroxyurea7naltrexone7tyrosine kinase inhibitors7vaccines7SGLT-2i6Glipizide6BLV6Varenicline6Camrelizumab6Cancer Drugs6Benzene6Doxy-PEP6SGLT-2is6Aprepitant6DEX6Dostarlimab6T-DXd6Azacitidine6Esketamine6NAC6Fidaxomicin6ITM6Minocycline6N-acetylcysteine6pMDIs6NBCA6Clofazimine6Filgotinib6Ravulizumab6Atomoxetine6Methylphenidate6amoxicillin-clavulanate6Acetylcysteine6Triamcinolone6anti-PD16Nitrous oxide6Octreotide6injectate6IL-1β6Lenalidomide6OAC6Venetoclax6antihypertensive drugs6n-BCA6Anti-TNF6Golimumab6Placebo6aripiprazole6b/tsDMARDs6Lansoprazole6MDPV6Mitomycin C6Nalbuphine6PCSK9 inhibitors6Sodium-Glucose Co-Transporter 2 Inhibitors6
Articles mentioning drugs
10,506 articles · page 660 of 876anticentromeretertiary rheumatology centersystemic sclerosismyositissystemic sclerosis (SSc)Sjögren’s diseaseSSc
…most universal (96.8%), and the most common autoantibodies were anticentromere (62.6%) and anti-Scl70 (21.9%).Anti-SSA was present in 9.1%, an…
Sirius RedSystemic sclerosis (SSc)
…e an increased submucosal area positive for fibrosis associated Sirius Red staining in SSc patients with lower GI involvement, compared wi…
carbon monoxideSjögren’s syndromesystemic sclerosisSSc
… the occurrence of isolated elevation of diffusion capacity for carbon monoxide (DLCO). While anti-Ro52 antibodies are usually linked to Sjögre…
HydroxychloroquineVasculopathySystemic sclerosisSScVEDOSSscleroderma
…ery early SSc (VEDOSS), absence of maculopathy, no therapy with Hydroxychloroquine. The OCTA acquisition consisted of 3 x 3 mm scans of the superf…
anticoagulantssclerodermaMeir Medical Centeranticoagulant therapycanceranticoagulation therapy
…ological markers, imaging-confirmed VTE events, medication use (anticoagulants), disease subtype and severity, and presence of comorbidities s…
P.072 Acute kidney injury and its implication on kidney function in patients with systemic sclerosis
bisphosphonateRambam hospitalP-ANCA vasculitisSystemic SclerosissepsisSRCrenal failure
…resented with AKI: 7 with SRC, 2 with P-ANCA vasculitis, 1 with bisphosphonate related acute tubular necrosis (ATN), 9 with cardio-renal mecha…
intravenous tocilizumabSSc-associated interstitial lung diseasesystemic sclerosis (SSc)
…NVC) findings in systemic sclerosis (SSc) patients treated with intravenous tocilizumab (TCZ), an anti-IL-6 receptor antibody, and to analyze the assoc…
VCAM-1SScSystemic SclerosisVasculopathypulmonary arterial hypertensionCardiovascular diseaseCVD
….04), more severe capillaroscopic findings (p=0.037) and higher VCAM-1 (1189.9 ng/ml vs 867.4 ng/ml, p=0.01).Conclusions We found a hi…
IT603lung fibrosis
…transcriptional profile linked to fibrosis. Inhibiting REL with IT603 reduced fibrotic markers in human dermal fibroblasts. Furthermo…
bronchodilatorsAirway diseaseSjogren’s syndromerheumatoid arthritisPubMedCochranesystemic sclerosisEmbaseScopusAD+1 more
…istory of smoking was not associated with AD in SSc. The use of bronchodilators or inhalation-steroids were used in 5-24% of SSc patients in co…
KL-6Interstitial lung disease (ILD)immunosuppressive therapysystemic sclerosis (SSc)systemic sclerosisSSc-ILD
… a protective effect. These findings highlight the potential of KL-6 for non-invasive monitoring and risk stratification in SSc-ILD.…